|
Up-regulated
|
|
SLC12A1
|
15.2
|
5.00E−05
|
SLC12A1 (solute carrier family 12 member 1)
|
Cation-coupled Chloride cotransporters
|
|
PAX8
|
15
|
0.00095
|
PAX8 (paired box 8)
|
DNA-binding transcription factor activity and RNA polymerase II core promoter sequence-specific DNA binding
|
|
PAX8-AS1
|
9
|
0.01
|
PAX8-AS1 (PAX8 antisense RNA 1)
|
A potential regulator of PAX8
|
|
HLA-V
|
8
|
0.03295
|
HLA-V (major histocompatibility complex, class I, V (pseudogene))
|
Pseudogene
|
|
RP11-384K6.6
|
8
|
5.00E−05
| |
Non-coding RNA
|
|
RP11-154J22.1
|
7.9
|
0.02655
| |
Non-coding RNA
|
|
RPS3AP6
|
6
|
0.00385
| |
RPS3A Pseudogene 6
|
|
MTRNR2L12
|
5.6
|
0.00435
|
MTRNR2L12 (MT-RNR2 like 12)
|
Pseudogene
|
|
C4BPA
|
5.4
|
0.0006
|
Complement Component 4 Binding Protein Alpha
|
RNA binding
|
|
RP1-283E3.4
|
5.2
|
0.03535
| |
Pseudogene
|
|
Down-regulated
|
|
GAD1
|
22.1
|
0.0154
|
Glutamate decarboxylase 1
|
Pyridoxal phosphate binding
|
|
RP4-740C4.5
|
18.7
|
0.0368
| |
pseudogene
|
|
IGHG1
|
8.9
|
5.00E−05
|
Immunoglobulin heavy constant gamma 1 (G1m marker)
|
Antigen binding
|
|
IGKV3-15
|
6.59
|
5.00E−05
|
Immunoglobulin kappa variable 3–15
|
Antigen binding
|
|
GCAT
|
6
|
5.00E−05
|
Glycine C-acetyltransferase
|
Pyridoxal phosphate binding
|
|
IGHV4-39
|
5
|
5.00E−05
|
Immunoglobulin heavy variable 4–39
|
Antigen binding
|
|
MYOM2
|
4
|
0.00035
|
Myomesin 2
|
Structural constituent of muscle
|
|
RP5-1198O20.4
|
4
|
0.0016
| |
LincRNA
|
|
SULT1A1
|
4
|
5.00E−05
|
Sulfotransferase family 1A member 1
|
Sulfotransferase activity and flavonol 3-sulfotransferase activity
|
|
CCL3
|
3.9
|
0.00285
|
C–C motif chemokine ligand 3
|
Immune system, chemokine activity
|
